REAL-TIME CONTRAST ENHANCED ULTRASOUND GUIDED RADIOFREQUENCY ABLATION OF CANINE PROSTATE: PILOT SURVIVAL STUDY

2009 ◽  
Vol 181 (4) ◽  
pp. 613
Author(s):  
Edouard J Trabulsi ◽  
Chengrong Mi ◽  
Xiang Jing ◽  
Shumin Wang ◽  
Leonard G Gomella ◽  
...  
2021 ◽  
Vol 11 ◽  
Author(s):  
Rui Zhang ◽  
Ming Xu ◽  
Xiao-yan Xie

BackgroundReninoma is a rare renal endocrine tumor that can cause secondary hypertension, characterized by hypertension, hypokalemia, high renin and aldosterone with normal aldosterone renin ratio (ARR), and occurs more in young female. Mainstream treatment option is surgery, but is less suitable for small or deep lesions, which makes ablation a promising alternative.Case presentationTwo young female with typical manifestations of reninoma, including hypertension, hypokalemia, high renin, high aldosterone and normal ARR, were treated successfully with real-time contrast-enhanced ultrasound guided radiofrequency ablation, and contrast-enhanced ultrasound was also performed before and after treatment for diagnosis and postoperative assessment. Afterward, their blood pressure and laboratory tests became normal and remained steady during the follow-up of 32 and 6 months, respectively.ConclusionContrast-enhanced ultrasound guided radiofrequency ablations is a promising alternative for reninoma treatment with comparable safety and efficacy with surgery, and has advantages especially in small or deep lesions.


2018 ◽  
Vol 44 (1) ◽  
pp. 310-317 ◽  
Author(s):  
Xiaojing Cao ◽  
Zhenxing Liu ◽  
Xiang Zhou ◽  
Chengyun Geng ◽  
Qing Chang ◽  
...  

2010 ◽  
Vol 20 (8) ◽  
pp. 2047-2056 ◽  
Author(s):  
Soon Ho Yoon ◽  
Kyoung Ho Lee ◽  
So Yeon Kim ◽  
Young Hoon Kim ◽  
Jee Hyun Kim ◽  
...  

2004 ◽  
Vol 171 (4S) ◽  
pp. 509-510
Author(s):  
D Brooke Johnson ◽  
David A. Duchene ◽  
Grant D. Taylor ◽  
Jeffrey A. Cadeddu

VASA ◽  
2019 ◽  
Vol 48 (2) ◽  
pp. 115-125 ◽  
Author(s):  
Xin Li ◽  
Daniel Staub ◽  
Vasileios Rafailidis ◽  
Mohammed Al-Natour ◽  
Sanjeeva Kalva ◽  
...  

Abstract. Ultrasound has been established as an important diagnostic tool in assessing vascular abnormalities. Standard B-mode and Doppler techniques have inherent limitations with regards to detection of slow flow and small vasculature. Contrast-enhanced ultrasound (CEUS) is a complementary tool and is useful in assessing both the macro- and microvascular anatomy of the aorta. CEUS can also provide valuable physiological information in real-time scanning sessions due to the physical and safety profiles of the administered microbubbles. From a macrovascular perspective, CEUS has been used to characterize aortic aneurysm rupture, dissection and endoleaks post-EVAR repair. With regard to microvasculature CEUS enables imaging of adventitial vasa vasorum thereby assessing aortic inflammation processes, such as monitoring treatment response in chronic periaortitis. CEUS may have additional clinical utility since adventitial vasa vasorum has important implications in the pathogenesis of aortic diseases. In recent years, there have been an increasing number of studies comparing CEUS to cross-sectional imaging for aortic applications. For endoleak surveillance CEUS has been shown to be equal or in certain cases superior in comparison to CT angiography. The recent advancement of CEUS software along with the ongoing development of drug-eluting contrast microbubbles has allowed improved targeted detection and real-time ultrasound guided therapy for aortic vasa vasorum inflammation and neovascularization in animal models. Therefore, CEUS is uniquely suited to comprehensively assess and potentially treat aortic vascular diseases in the future.


Sign in / Sign up

Export Citation Format

Share Document